Aloe vera for Health & Longevity - Quick Reference Sheet

Aloe vera for Health & Longevity

Created on 06/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Aloe vera has two distinct parts. The clear inner gel speeds healing of burns and minor wounds and calms vein and mouth inflammation, and a purified gel modestly lowers blood sugar. The leaf latex and crude whole-leaf forms can cause cramping, low potassium, and rare liver or kidney harm, plus a possible cancer signal. Form and purity matter most. (Full Review)

Protocol

Topical Burns & Wounds
Inner-leaf gel 2–3×/day
Apply pure inner-leaf gel to clean skin until healed
Oral Metabolic Use
~100–300 mg gel complex 1–2×/day
Decolorized low-aloin gel for 4–8 weeks, taken with or before meals
Oral Dosing Pattern
Split dosing with meals
Aligns absorption-slowing with carbohydrate intake; topical applied as needed
Time to effect
Topical Burns & Wounds
Days
Benefits appear over days as healing accelerates
Oral Metabolic Effects
4–8 weeks
Consistent use needed before measurable glucose or lipid change

Benefits

Contraindications
  • Pregnancy or breastfeeding (oral latex/whole-leaf)
  • Inflammatory bowel disease (Crohn's disease, ulcerative colitis) or intestinal obstruction
  • Chronic kidney disease (eGFR <30 mL/min/1.73 m²)
  • Significant liver disease
  • Known Liliaceae-family plant allergy (topical use)
Key Interactions
  • Antidiabetic drugs (metformin, sulfonylureas, insulin)
  • Digoxin
  • Diuretics (furosemide, hydrochlorothiazide)
  • Stimulant laxatives (senna, bisacodyl)
  • NSAIDs (ibuprofen)
  • Blood-sugar-lowering supplements (berberine, cinnamon, chromium, bitter melon, fenugreek)
  • Potassium-depleting botanicals (licorice)
  • Topical corticosteroids

Risk & Side Effects

  • High: Laxative effects, cramping & diarrhea; electrolyte disturbance & low potassium
  • Medium: Carcinogenicity signal from oral whole-leaf extract; hepatotoxicity
  • Low: Kidney injury at high latex doses; allergic & skin reactions
  • Speculative: Blood-sugar-lowering interaction in non-diabetics; pregnancy-related risk

Monitoring

Marker Target Why
Fasting glucose 70–85 mg/dL Primary target of oral gel's metabolic effect
HbA1c <5.4% Tracks sustained glycemic change
Lipid panel (total, LDL, HDL, triglycerides) LDL <100 mg/dL; triglycerides <90 mg/dL Captures possible lipid-lowering effect
Potassium 4.0–4.5 mmol/L Detects hypokalemia from latex/whole-leaf use
eGFR (kidney filtration rate) >90 mL/min/1.73 m² Screens for kidney vulnerability and injury
ALT / AST (liver enzymes) ALT <25 U/L; AST <25 U/L Detects rare liver injury from oral aloe

Cadence: Baseline before oral use; recheck at 6–8 weeks, then every 3–6 months if use continues, and sooner if symptoms of low potassium, liver, or kidney problems appear

Qualitative Assessment

  • Faster visible wound or burn closure and reduced redness (topical use)
  • Reduced oral pain, burning, or gum inflammation (mucosal use)
  • Improved post-meal energy stability and fewer glucose spikes (oral metabolic use)
  • Absence of cramping, diarrhea, or unusual fatigue (a marker that the chosen form is well tolerated)